White Bagging vs Brown Bagging: What Specialty Pharma Should Know
Specialty pharmaceuticals continue to shift the way care is delivered across the healthcare system. As patients utilize more of these medications, the complexity of how medications are procured, routed, and administered also grows.
Two models that frequently come up in specialty medication distribution are white bagging and brown bagging. While both approaches move drugs outside the traditional physician “buy-and-bill” model, they differ meaningfully in the workflow, risk, and operational impact.
Understanding these differences is important for healthcare service providers, patient support hubs, and payers all working to balance cost management, access, and care delivery efficiency.
What Is Specialty Medication?
Specialty medications are prescription drugs used to treat serious, chronic, or complex conditions. These medications often:
- Require special handling or refrigeration. Most biologics (large molecules) must be stored at 2–8º Celsius to maintain their efficacy. It is also critical to maintain these temperatures and not to drop below to prevent the medication from freezing, as freezing could be just as detrimental as overheating.
- Need to be injected or infused by a healthcare professional. Some specialty medications require physician or healthcare provider oversight for administration because they require monitoring for side effects of the medication, or they require specialized complex handling that is not suitable for patients’ self-administration. The FDA (Federal Drug Administration) can mandate in their label for an approved medication the administration requirements for that medication.
- Are high cost and may require prior authorization. A specialty medication typically costs over $1,000 a month for a 30-day supply. There are many medications that exceed $100,000 annually, with some gene/cell therapies that can cost over $1 million for the therapy.
Because of this, specialty medications often follow a different process than medications picked up at a local retail pharmacy.
READ MORE: How Long Do Prior Authorizations Take in Specialty Pharma?
What Is Brown Bagging?
Brown bagging means the specialty pharmacy ships the medication directly to the patient, and the patient then brings the medication to their medical appointment.
Example of Brown Bagging:
- A provider prescribes a specialty medication for a patient.
- The patient’s health insurance plan routes the prescription to a specialty pharmacy.
- The specialty pharmacy dispenses the medication.
- The medication is shipped directly to the patient (with refrigeration).
- The patient receives a refrigerated injection at home.
- The patient stores the medication properly in their refrigerator.
- The patient then brings it to the infusion center for treatment.
- The healthcare provider verifies the medication and administers therapy.
What Is White Bagging?
White bagging means the specialty pharmacy ships the medication directly to the provider’s office, infusion center, or hospital for the patient’s scheduled treatment.
Example of White Bagging:
- A provider prescribes a specialty medication for a patient.
- The patient’s health insurance plan routes the prescription to a specialty pharmacy.
- The specialty pharmacy dispenses the medication.
- The medication is shipped directly to the provider (with refrigeration).
- The provider receives and safely stores the medication under recommended storage conditions.
- The medication is matched to the patient and appointment is scheduled for administration.
- The healthcare provider verifies the medication and administers therapy at the patient visit.
Why Does This Matter for Patients?
While both white bagging and brown bagging methods are designed to get the right medication to the right place, the experience can be very different for patients. With white bagging, patients generally do not handle the medication. With brown bagging, patients may need to:
- Be available to receive the shipment of medication.
- Properly store the medication (usually refrigeration).
- Bring the medication to the appointment.
- Ensure the medication is not damaged upon receipt or during transportation.
Why Does This Matter for Pharmaceutical Brand Manufacturers?
For brand manufacturers, the white bagging process and brown bagging process affect patient access, adherence, and their outcomes, in addition to simply getting your product distributed across its unique drug handling channels.
With white bagging, brand manufacturers benefit from:
- A tightly controlled chain of custody in a healthcare setting
- Lower risk of storage and handling problems
- A higher likelihood of administration due to the clinical team being aware of the medication
With brown bagging, brand manufacturers must overcome:
- Greater reliance on patient accountability for storage, handling and transport
- Increased risk of administration delays
- Increased risk of compromised product integrity due to mishandling and storage
Manufacturers have to consider and overcome for these above issues with brown bagging and implement patient support programs that help increase patient satisfaction, access, and patient safety, while reducing friction.
Why Do Insurance Plans Have Both Brown Bagging and White Bagging?
Insurance companies may require brown or white bagging to help manage the cost of the specialty medication and control where the medication is dispensed. These programs often route prescriptions through a designated specialty pharmacy rather than allowing providers to source the medication directly. Insurers can negotiate better pricing by working directly with a specialty pharmacy.
For patients, it is worthwhile checking with the insurance company as to their policies and recommendations for how to obtain specialty medications. White bagging is generally less burdensome than brown bagging because of the logistics of patients storing and transporting their own medication, as well as chain of custody concerns.
There is not a standard fixed dollar difference between brown bagging and white bagging. The cost differential varies widely by drug, insurance plan contract, site of care, and the patient’s benefit plan design.
READ MORE: The Importance of Price Transparency for Uninsured Patients
How careviso Helps
Navigating specialty medication logistics can be confusing for patients and providers. At careviso, we help all who are involved in the healthcare process understand payer requirements, network plan design, pricing, site of care, step therapy, and prior authorization requirements, all within our seeQer platform. This better helps patients navigate treatment logistics and begin their therapy to move treatment forward.
Discover how seeQer informs patients and transforms practice.
Schedule a seeQer demonstration of benefits verifications, cost assessments, and other essential tasks in the platform. Learn how seeQer can help your organization reduce administrative burden, transform cumbersome processes, and provide transparency that empowers patients in a complex and ever-changing industry.

